Compounds > catechin

catechin and Fatty Liver

catechin has been researched along with Fatty Liver in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19906 (21.43)18.7374
1990's0 (0.00)18.2507
2000's5 (17.86)29.6817
2010's16 (57.14)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F1
Ceballos, G; Hidalgo, I; Meaney, E; Nájera, N; Pérez-Durán, J; Valdespino-Vazquez, Y; Villarreal, F1
Di Giacomo, M; Ferramosca, A; Zara, V1
Adamo, AM; Bettaieb, A; Cremonini, E; Daveri, E; Haj, FG; Kalanetra, KM; Karakas, S; Mills, DA; Oteiza, PI; Wang, Z1
Dai, Z; Feng, S; Huang, J; Liu, A; Lu, W; Reuhl, K; Wang, H; Yang, CS1
Bae, UJ; Chae, BM; Chae, SW; Jung, SJ; Oh, MR; Park, BH; Park, IW; Park, J; Ryu, GS1
Chen, W; Hu, D; Ke, H; Li, Y; Su, H; Xie, L; Zheng, X1
Fung, ML; Ho, CT; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J1
Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H1
Bay, BH; Farah, BL; Singh, BK; Sinha, RA; Wu, Y; Yang, CS; Yen, PM; Zhou, J1
Chakrapani, LN; Durairajan, S; Ganesan, T; J, T; Krishnan, TR; Mangaiah, S; Narasimhan, K; Nathakattur Saravanabavan, S; Periandavan, K; Srinivasan, A; Velusamy, P; Walter, CE1
Im, JA; Kim, Y; Lee, H; Park, JY1
Chan, YC; Chang, SJ; Liu, HW; Wang, MF; Wei, CC1
Carnier, J; de Souza, GH; Lira, FS; Mennitti, LV; Oliveira, JL; Oller do Nascimento, CM; Oyama, LM; Ribeiro, EB; Santamarina, AB; Santana, AA; Silva, FP1
Bose, M; Ju, J; Lambert, JD; Reuhl, KR; Shapses, SA; Yang, CS1
Hashimoto, O; Inoue, K; Koga, H; Nakamura, T; Nakayama, H; Otabe, S; Sata, M; Sivakumar, R; Torimura, T; Ueno, T; Yamada, K; Yuan, X1
Hou, J; Kawai, K; Li, XK; Luo, XY; Sugiyama, T; Takahara, T; Takemoto, M; Takeuchi, M; Tsukada, K; Zhong, L1
Bruno, RS; Masterjohn, C1
Aburada, M; Kamiya, T; Kamiya-Sameshima, M; Miyamoto, K; Nagamine, R; Sai, Y; Shimada, T; Takagaki, K; Tokuhara, D; Tsubata, M1
Bunzendahl, H; Connor, HD; Froh, M; Lemasters, JJ; Lind, H; Mason, RP; Thurman, RG; Zhong, Z1
Campbell, C; Chavin, KD; Cheng, G; Donovan, JL; Evans, Z; Fiorini, RN; Haines, JK; Markowitz, JS; May, HD; Milliken, CE; Rodwell, D; Schmidt, MG1
Bahcecioglu, IH; Dagli, AF; Kuzu, N; Ozercan, IH; Sahin, K; Ustündag, B1
Kovách, G; Salamon, F1
Beck, P; Boda, Z; Dalmi, L; Misz, M; Pfliegler, G; Weisz, G1
Meiss, R; Rassat, J; Themann, H1
Kostova, N; Krŭstev, Z; Lukanov, L; Maleev, A; Tsvetkova, V1
Gajdos, A; Gajdos-Török, M; Horn, R1
Gajdos, A; Gajdos-Tërök, M; Horn, R1

Reviews

2 review(s) available for catechin and Fatty Liver

ArticleYear
Antioxidant dietary approach in treatment of fatty liver: New insights and updates.
    World journal of gastroenterology, 2017, Jun-21, Volume: 23, Issue:23

    Topics: Animals; Anthocyanins; Antioxidants; Carotenoids; Catechin; Coumestrol; Curcumin; Energy Metabolism; Fatty Liver; Glucosinolates; Humans; Imidoesters; Isothiocyanates; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Nutritional Sciences; Oxidative Stress; Oximes; Polyphenols; Quercetin; Resveratrol; Stilbenes; Sulfoxides; Xanthophylls

2017
Therapeutic potential of green tea in nonalcoholic fatty liver disease.
    Nutrition reviews, 2012, Volume: 70, Issue:1

    Topics: Catechin; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Tea

2012

Other Studies

26 other study(ies) available for catechin and Fatty Liver

ArticleYear
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:9

    Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides

2011
Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis.
    The Journal of nutritional biochemistry, 2020, Volume: 77

    Topics: Adiponectin; Animals; Catechin; CD36 Antigens; Cholesterol, LDL; Disease Models, Animal; Fatty Liver; Fructose; Hepatocytes; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Perilipin-2; Perilipin-3; Perilipins; Risk Factors; Triglycerides; Uncoupling Protein 2

2020
(-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance.
    Redox biology, 2018, Volume: 14

    Topics: Animals; Caco-2 Cells; Catechin; Diet, High-Fat; Fatty Liver; Humans; Insulin Resistance; Intestinal Mucosa; Intestines; Male; Mice, Inbred C57BL; Permeability; Protective Agents

2018
Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice.
    Molecular nutrition & food research, 2018, Volume: 62, Issue:4

    Topics: Adipose Tissue; Animals; Bile Acids and Salts; Blood Glucose; Catechin; Fatty Liver; Insulin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Tea

2018
Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
    The American journal of Chinese medicine, 2018, Volume: 46, Issue:3

    Topics: Animals; Catechin; Cell Survival; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Obesity; Phytotherapy; Plant Extracts; Sirtuin 1; Tea; Weight Gain

2018
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Free radical biology & medicine, 2018, Volume: 126

    Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biflavonoids; Catechin; Diet, High-Fat; Fatty Acids, Nonesterified; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Liver; Lysosomes; Metabolic Networks and Pathways; Mice; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidation-Reduction; Oxidative Stress; Proanthocyanidins

2018
Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
    European journal of nutrition, 2014, Volume: 53, Issue:1

    Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cyclooxygenase 2; Diet, High-Fat; Down-Regulation; Fatty Liver; Female; Fibrosis; Forkhead Transcription Factors; Inflammation; Liver; Matrix Metalloproteinase 2; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Tumor Necrosis Factor-alpha

2014
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
    Cancer letters, 2014, Jan-01, Volume: 342, Issue:1

    Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha

2014
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adenylate Kinase; Animals; Autophagy; Catechin; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Phagosomes; Tea

2014
EGCG mediated downregulation of NF-AT and macrophage infiltration in experimental hepatic steatosis.
    Experimental gerontology, 2014, Volume: 57

    Topics: Animals; Antioxidants; Catechin; Cell Adhesion Molecules; Cholesterol, Dietary; Down-Regulation; Drug Evaluation, Preclinical; Fatty Liver; Liver; Macrophages; Male; NF-kappa B; NFATC Transcription Factors; Phytotherapy; Plant Extracts; Rats, Wistar; Tumor Necrosis Factor-alpha

2014
Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model.
    BMC complementary and alternative medicine, 2015, Jun-16, Volume: 15

    Topics: Catechin; Fatty Liver; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Models, Biological; Phenols

2015
Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
    Journal of agricultural and food chemistry, 2015, Sep-30, Volume: 63, Issue:38

    Topics: Aging; Animals; Camellia sinensis; Catechin; Dietary Supplements; Fatty Liver; Female; Glucose; Glucose Transporter Type 4; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Muscle, Skeletal; Plant Extracts; Sterol Regulatory Element Binding Protein 1

2015
Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: AMP-Activated Protein Kinases; Animals; Blotting, Western; Body Weight; Catechin; Diet, High-Fat; Enzyme Activation; Fatty Liver; Male; Mice; Plant Extracts; Protein Serine-Threonine Kinases; Tea

2015
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
    The Journal of nutrition, 2008, Volume: 138, Issue:9

    Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Catechin; Diet; Dietary Fats; Eating; Fatty Liver; Feces; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Tea

2008
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.
    International journal of molecular medicine, 2009, Volume: 24, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipose Tissue; Animals; Catechin; Deoxyguanosine; Fatty Liver; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Mice; Mice, Transgenic; Sterol Regulatory Element Binding Protein 1

2009
Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model.
    Biochemical and biophysical research communications, 2012, Jan-06, Volume: 417, Issue:1

    Topics: Animals; Antioxidants; Apoptosis; Biflavonoids; Catechin; Cell Line; Cytokines; Fatty Liver; Hepatocytes; Liver Transplantation; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Reperfusion Injury; RNA, Messenger; Tissue Donors; Tumor Necrosis Factor-alpha

2012
Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models.
    European journal of pharmacology, 2012, Feb-29, Volume: 677, Issue:1-3

    Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus; Disease Models, Animal; Fatty Acids; Fatty Liver; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Liver Function Tests; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Pinus; Plant Bark; Plant Extracts; Proanthocyanidins; RNA, Messenger; Tomography, X-Ray Computed

2012
Polyphenols from Camellia sinenesis prevent primary graft failure after transplantation of ethanol-induced fatty livers from rats.
    Free radical biology & medicine, 2004, May-15, Volume: 36, Issue:10

    Topics: Alanine Transaminase; Aldehydes; Animals; Antioxidants; Bile; Camellia; Catechin; Central Nervous System Depressants; Electron Spin Resonance Spectroscopy; Ethanol; Fatty Liver; Female; Flavonoids; Free Radical Scavengers; Free Radicals; Graft Survival; Liver Transplantation; Necrosis; Phenols; Polyphenols; Rats; Rats, Sprague-Dawley

2004
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:3

    Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Energy Intake; Energy Metabolism; Fatty Liver; Hepatocytes; Liver; Liver Circulation; Male; Mice; Mice, Obese; Necrosis; Reperfusion Injury

2005
Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:8 Pt 2

    Topics: Animals; Antioxidants; Catechin; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Liver; Male; Rats; Rats, Sprague-Dawley

2008
Effects of (+)-cyanidanol-3 on chronic liver injury.
    Acta physiologica Hungarica, 1984, Volume: 64, Issue:3-4

    Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzopyrans; Catechin; Chronic Disease; Diabetes Complications; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged

1984
Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Therapia Hungarica (English edition), 1984, Volume: 32, Issue:1

    Topics: Adult; Aged; Blood Coagulation Tests; Catechin; Clinical Enzyme Tests; Fatty Liver; Female; Hemostasis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Time Factors

1984
[The effect of (+)-cyanidanol-3 on toxic fatty infiltration of liver parenchyma (author's transl)].
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:2

    Topics: Animals; Benzopyrans; Catechin; Ethanol; Fatty Liver; Galactosamine; Male; Pentachlorophenol; Polychlorinated Biphenyls; Rats

1982
[Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Vutreshni bolesti, 1985, Volume: 24, Issue:5

    Topics: Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Fatty Liver; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged

1985
[Action of (+)-catechin on experimental liver steatosis in the white rat].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1970, Volume: 164, Issue:10

    Topics: Adenosine Triphosphate; Animals; Catechin; Fatty Liver; Lipid Metabolism; NAD; Oxidoreductases; Rats

1970
The effect of (+)-catechin on the hepatic level of ATP and the lipid content of liver during experimental steatosis.
    Biochemical pharmacology, 1972, Feb-15, Volume: 21, Issue:4

    Topics: Adenosine Triphosphate; Animals; Catechin; Dietary Proteins; Ethanol; Ethionine; Fatty Liver; Female; Flavonoids; Lipid Metabolism; Liver; Malonates; NAD; Orotic Acid; Rats

1972